According to Grand View Research, the global medical cannabis market is expected to reach USD 55.8 billion by 2025. Increasing use of cannabis for medical purposes is one of the key factors that drives the market. The CBD market is projected to experience rapid growth in the cannabis industry due to its medical benefits, which are highly in demand. According to a report published by Hemp Business Journal, the CBD consumer market is expected to reach $2.1 billion by 2020. Chineseinvestors.com, Inc. (OTC: CIIX), Terra Tech Corp. (OTC: TRTC), Cannabis Science, Inc. (OTC: CBIS), WEED, Inc. (OTC: BUDZ), Aurora Cannabis Inc. (OTC: ACBFF)
Hemp Business Journal Founder and Publisher, Sean Murphy, explained, “The CBD Report is the culmination of more than a year of focused market research. We’ve been to Israel, Europe, Canada and to farms, labs and retailers across the U.S. to cover the hemp industry. By analyzing consumer sales in the hemp and marijuana industries, we’ve provided the first view to investors, executives and regulators on what’s really happening with CBD, the hottest category in the broader multi-billion dollar cannabis industry.”
Chineseinvestors.com, Inc. (OTCQB: CIIX) announced breaking news on November 21st that, “Its wholly owned foreign enterprise, CBD Biotechnology Co. Ltd., has teamed up with Chinese beauty influencer, The Godfather of Beauty, for the launch of its “CBD Magic Hemp Series” skincare line on China’s largest e-commerce retailer Alibaba. Within minutes of its launch on the ‘China Taobao Live Broadcasting Celebrity Show’, over 91 units from the CBD Magic Hemp Series skincare line were purchased by excited consumers, with over 40,000 views during the first broadcast. See broadcast at http://www.youtube.com/watch?v=YsKEv-4-Dyw.
Taobao, part of the Alibaba Group, is the largest shopping site in Asia with upwards of 500 million registered users. With years of experience in live, online marketing on the Taobao Platform, “The Godfather of Beauty is an Internet celebrity with over 60,000 active followers. Through its partnership with Taobao and with The Godfather of Beauty, the Company has an amazing opportunity to expand its e-commerce presence in China through live product demonstrations and social interaction with fans.”
“It is well documented that ancient Chinese recognized the medicinal properties of the hemp plant. Now this ancient remedy is re-emerging in the Chinese skincare industry and CBD Biotechnology Co. Ltd. is pleased to be among the first to bring such a novel skincare line to market,” says Warren Wang, CEO of ChineseInvestors.com, Inc. “The success of the initial launch of the CBD Magic Hemp Series skincare line on Taobao solidifies our belief that Chinese consumers recognize that the anti-inflammatory agents and anti-oxidants contained in hemp-extract can have positive effects on the skin.”
“We are excited about the Company’s partnerships with Taobao and The Godfather of Beauty and are pleased with consumer reaction to the initial launch and product,” says CBD Biotechnology Co. Ltd. CEO, Summer Yuan. “China is the second largest cosmetics consumer market in the world with a market size of more than 300 billion CNY, or roughly 45 billion USD. With such a large consumer audience, we see huge possibilities for continued growth and plan to continue to develop new, innovative products for the Chinese market and will continue to partner with dynamic influencers throughout mainland China to spread the word about the CBD Magic Hemp Series product line. We anticipate explosive growth in the coming year.”
Terra Tech Corp. (OTCQX: TRTC) recently provided an update on the planned joint venture with NuLeaf Sparks Cultivation LLC and NuLeaf Reno Production LLC, in Nevada, which was announced on August 30, 2017. A wholly-owned subsidiary of Terra Tech has made a convertible loan to NuLeaf Sparks, and a convertible loan to NuLeaf Reno, both of which will automatically convert to 50% ownership of the NuLeaf entities upon approval by the State of Nevada. The joint venture is expected to fast track Terra Tech’s cultivation and production facilities, allowing it to increase supply of its proprietary IVXX wholesale brand to meet the growing demand for cannabis products throughout Nevada.
Cannabis Science, Inc. (OTC: CBIS) that its expansions plans are well underway as it has signed agreements to acquire and officially open the first Cannabis Science PRE ICO Medical Marijuana dispensary, in Los Angeles, California. “Attaining this first PRE ICO Dispensary in L.A. is a huge step for Cannabis Science as it opens the door to speed up our planned expansion in the Los Angeles area and eventually Californiastatewide,” stated Cannabis Science Inc., President & CEO, Co-Founder, Mr. Raymond C. Dabney. “This is a prime example of our resilient and aggressive negotiations to acquire multiple pharmacies across the Los Angeles area. Finalizing this acquisition is just the first step of many that Cannabis Science will be taking to establish a statewide presence, with a nationwide future goal.”
WEED, Inc. (OTC: BUDZ) is a multi-national, multi-faceted, vertically integrated World Class Cannabis organization. WEED is structured as a holding company doing business through its divisions, wholly owned subsidiaries and strategically placed collaborative partners to achieve & promote our Global Brand. WEEDs plans commence with extensive background research into the biomedical and phytochemical applications and Cannabis related treatments focused on the human endo-cannabinoid system, more specifically, targeted research into genomics, metabolomics, phytochemicals and secondary metabolites in both Australia and the USA, will result in the production of the required scientifically valid, evidence based, cannabis strains and identification and production of disease specific medicines.
Aurora Cannabis Inc. (OTCQX: ACBFF) it has formally commenced its offer (the “Offer”) to purchase all of the issued and outstanding common shares of CanniMed Therapeutics Inc. for consideration consisting of common shares of Aurora. Notice and advertisement of the Offer was placed in the November 24, 2017 edition of the Globe & Mail, and a takeover bid circular will be mailed to CanniMed shareholders. In addition, Aurora will file the offer and takeover bid circular and related documents on SEDAR. The Offer Documents will also be available on Aurora’s website at http://www.auroramj.com and shareholders are invited to visit cannimed.auroramj.com for further information.